• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Investment Round-up (May 2023)

By Femtech Insider Investment Round-ups, News May 31, 2023
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

News, Partnership December 16, 2024
Ro Partners with Lilly to Offer Direct Access to Zepbound Weight Loss Treatment
Investment, News, Pelvic Health, Research April 23, 2025
Digital Health Company Amara Therapeutics Launches US Clinical Trial for Overactive Bladder Treatment Following €1.8M Funding Round
Recent Posts
  • FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
  • Why Investors Are Betting Big on Incontinence
  • Australian Medtech NinaMED Launches with $13.75M to Develop Non-Invasive Wearable for Overactive Bladder
  • Inside SPRIND’s Push to Build a Continuous Hormone Monitoring Industry in Europe
  • BlueWind Medical Raises $47.8M to Commercialize Implantable Neuromodulation Device for Urgency Urinary Incontinence

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2026. All rights reserved.